On May 31, 2019 bluebird bio, Inc. (Nasdaq: BLUE) reported that the Company will hold a conference call to discuss data presented at the European Hematology Association (EHA) (Free EHA Whitepaper) Annual Meeting on Friday, June 14 at 8:00 am ET (Press release, bluebird bio, MAY 31, 2019, View Source [SID1234536718]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

In addition, members of the management team will present at the following upcoming investor conferences:

Jefferies 2019 Healthcare Conference, Tuesday, June 4, at 11:30 am ET at The Grand Hyatt, New York, NY
Goldman Sachs 40th Annual Healthcare Conference, Tuesday, June 11 at 10:00 am PT at the Terranea Resort, Rancho Palos Verdes, CA
To access the live webcasts of bluebird bio’s presentations, please visit the "Events & Presentations" page within the Investors & Media section of the bluebird bio website at View Source Replays of the webcasts will be available on the bluebird bio website for 90 days following the events.